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RESUMO – O peptídeo natriurético atrial felino (PNA) é um hormônio sintetizado pelo miocárdio
cardíaco atrial que, uma vez liberado na circulação, produz diurese, natriurese e vasodilatação
periférica. Nós recentemente isolamos, sequenciamos e estabelemos a expressão cardíaca
normal do PNA felino. No presente estudo, nós apresentamos o número de cópias gênicas do
PNA em gatos. Foram extraídas amostras de DNA genômico do sangue periférico humano e
felino, as quais foram purificadas e digeridas com as enzimas de restrição EcoRI, BamHI e
HindIII, com posterior realização da técnica de Southern Blots. Primers para PCR,
confeccionados para regiões de alta conservatividade entre espécies, foram utilizados para
amplificação, clonagem e sequenciamento de um produto de 900 pares de bases, posteriormente
utilizado como sonda de DNA. O gene do PNA felino possui uma única cópia gênica, a exemplo
do PNA humano. Devido a sua similaridade, sondas de DNA felino puderam ser utilizadas para
a hibridização de DNA genômico tanto do gato como do homem.
Palavras chave:  peptídeo natriurético atrial, PNA, gato, gene, copia gênica, coração.
ABSTRACT – Atrial natriuretic peptide (ANP) is a hormone normally synthesized by the cardiac
atrial myocardium that once released, produces diuresis, natriuresis and peripheral vasodilation.
We have recently isolated, sequenced and assessed the normal cardiac expression of feline
ANP.  In this study, we report on the number of copies of the feline ANP gene, which could have
an effect on future molecular biology studies of ANP gene expression in cat models of
cardiovascular disease. Cat and human genomic DNA (gDNA) were extracted for Southern
blotting from blood. The purified DNA was digested with the restriction enzymes EcoRI, BamHI
and HindIII followed by agarose gel electrophoresis and blotting onto nytran membranes. A feline
ANP cDNA probe of approximately 900 base pairs was used for hybridization of the membranes.
The results of Southern blotting showed that both the feline and human genomes contain a single
copy of the ANP gene.
Key words: atrial natriuretic peptide, ANP, cat, feline, human, gene copy, heart.
Introduction
Atrial natriuretic peptide (ANP) is a
hormone normally synthesized by the cardiac
atrial myocardium (CHAPEAU et al., 1985;
COLBATZKY et al., 1993) and stored in
cytoplasmic granules as a prohormone
(MIFUNE et al., 1992; FORSSMANN et al.,
1998; TURK, 2000).  Upon release into the
circulation it is cleaved to the mature peptide
causing, diuresis, natriuresis and peripheral
vasodilation (LEVIN et al., 1998; MELO et al.,
2000; TURK, 2000). A positive correlation has
been established between plasma ANP
concentrations and the severity of heart failure
in several species with various forms of heart
disease including, dilated cardiomyopathy,
chronic valvular regurgitation, and other
anomalies causing atrial distension (ITOH et
al., 1988; SUNDSFJORD et al., 1988;
LERMAN et al., 1993; HAGGSTROM et al.,
1994; HALL et al., 1994; CLERICO et al.,
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1996; MUDERS et al., 1997; NUMATA et al.,
1998; CHENBURNETT, 1999; FRUHWALD
et al., 1999a; FRUHWALD et al., 1999b).
Atrial natriuretic peptide was first described
in human beings (DE BOLD et al., 1981) and
its gene was subsequently cloned and
sequenced few years later (OIKAWA et al.,
1984). The nucleotide and amino acid
sequence of ANP has been established for
many species, including rats, rabbits, pigs,
horses, cattle, sheep, dogs (KANGAWA et al.,
1984; NAKAYAMA et al., 1984; SEIDMAN et
al., 1984; OIKAWA et al., 1985; VLASUK et
al., 1986; MAGERT et al., 1990; AITKEN et
al., 1999) and recently determined in our
laboratory for domestic cats (BIONDO et al.,
2002). No studies either on the number of
copies or on mutations of the feline ANP gene
have been performed to date, however in man
it has been shown that a single copy of the
ANP gene exists (LEWICKI et al., 1986).
Our laboratory is currently evaluating the
potential of ANP as a cardiac marker of heart
failure in cats. Cats develop a form of
hypertrophic cardiomyopathy (HCM) that may
make them a good model of heart failure with
HCM of man (KITTLESON et al., 1999). We
are also evaluating the plasma levels of
natriuretic peptides in a variety of feline
cardiovascular diseases and investigating the
potential correlations between the expression
ANP gene and feline myocardial diseases as
well (BIONDO et al., 2001).
The purpose of this study is to determine
the number of copies of the ANP gene within
the feline genome, which could be important
in future studies concerning genetic
manipulation of ANP gene expression in feline
myocardial cell cultures and the inheritance
patterns of feline HCM.
Material and Methods
Feline and human whole blood samples
were obtained and processed within 6 hours
after collection. Genomic DNA (gDNA) was
extracted from blood using a commercial kit.a
DNA concentrations were determined in two
different dilutions by spectrophotometry at 260
nm, and purity evaluated by the 260/280 nm
ratio and gel analysis. Ten mg of each sample
was digested for 3 hours at 37 ºC with 1ml of
restriction enzymes EcoRI, BamHI and
HindIII, b 2 ml of respective buffer and water
up to 20 ml. The total volume of each sample
was loaded onto a 1.5 % commercial agarose
gel for electrophoresis. Following separation
the DNA was visualized using ultraviolet light
and denatured in a solution 0.4 M of NaOH
and 0.8 M of NaCl. The gel was then blotted
for 16 hours with 20X Standard Saline Citrate
(SSC) solution onto a nytran membrane. c After
blotting the DNA was fixed to the nytran
membrane by ultra violet crosslinking.
The cloning and sequencing were done
using standard techniques (MANIATIS,
1987). The upstream and downstream
consensus sequence primers (5'
ACGACGCCAGCATGAGCTCCTTC 3' and
5' CGGAAGCTGTTGCAGCCCAG 3') were
designed using known feline ANP gene
sequence previously obtained in our
laboratory.  Polymerase chain reactions
(PCR) were performed under standard
conditions.  The thermocycle profile included
an initial denaturing step (3 min at 95 ºC), 35
cycles of denaturing (30s at 95 ºC), annealing
(30s at 62 ºC) and extension (45s at 72 ºC),
a final extension (7 min at 72 ºC) and a 4 ºC
end step.  The resulting PCR product was
purified using a commercial PCR purification
kit. d The purified PCR product was ligated into
a commercial vectore following the
manufacturer protocol. Plasmids identified
with the properly sized inserts were sent to a
commercial DNA sequencing facility. f
Sequence results were compared to those of
feline ANP in our databank and a piece of 900
base pairs was selected as a probe.
Probe labeling and Southern blot analysis
a Wizardâ genomic DNA purification kit, cat. 1125,
Promega, Madison, WI, USA.
b Promega Restriction Enzymesâ, Promega,
Madison, WI, USA.
c Nytranâ Membranes, Schleicher & Schuell, Inc.,
Keene, NH, USA.
d Wizardâ PCR preps DNA purification kit, cat.
A7170, Promega, Madison, WI, USA.
e pGEMâ- T Easy Vector System I, cat. A1360,
Promega, Madison, WI, USA.
f ACGTâ Inc, Northbrook, IL, USA.
g Transcendâ Non-Radioactive Translation Detection
Systems, Promega, Madison, WI, USA.
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were performed using a commercial
enhanced chemiluminescent kit following the
manufacturer ’s protocol.g Probes were
labeled with fluorescein-II-dNTP (Fl-dNTP) in
a random primed synthesis reaction. After
hybridization, anti-fluorescein antibody
conjugated to a horseradish peroxidase was
added to the blot. Detection of the bound
horseradish peroxidase was done using the
kit’s detection reagents. After the labeling,
hybridization and washing the blot was
exposed to a Rx hyperfilm  for 5 minutes. The
film was developed and analyzed.
Results
The digestion of cat and human chromosomal
DNA was successfully performed (FIGURE
1), the Southern blot analyses conducted and
the results registered (FIGURE 2). The
digestions with all three restriction digestion
enzymes resulted in single bands. EcoRI and
HindIII digestion resulted in products about 5
to 8 kilobase long. The digestion with BamHI
resulted in a band of about 1.2 kb,
corresponding to the size of the feline ANP
gene.
FIGURE 1 – 1.5% AGAROSE GEL SHOWING THE RESTRICTION ENZYME DIGESTION OF CAT AND
HUMAN DNA. LANES 1,2 AND 3 ARE HUMAN PRODUCTS FROM DIGESTION WITH
EcoRI, BamHI AND HindIII, RESPECTIVELY. LANES 4,5 AND 6 ARE FELINE PRODUCTS
FROM DIGESTION WITH EcoRI, BamHI AND HindIII, RESPECTIVELY. THE SIZE OF
THE PRODUCTS ARE SHOWN IN KILOBASES (Kb).
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FIGURE 2 – SOUTHERN BLOT ANALYSIS OF CAT AND HUMAN ANP GENES. DIGESTION WAS
PERFORMED WITH EcoRI (LANES 1 AND 4), BamHI (LANES 2 AND 5) AND HindIII
(LANES 3 AND 6). THE SIZE OF THE PRODUCTS ARE SHOWN IN KILOBASES (Kb).
THE SIZE OF THE DIGESTION BY BamHI IS ABOUT THE SIZE OF THE ANP GENE IN
BOTH SPECIES.
Discussion and Conclusions
The application of Southern blots analysis
has shown that ANP gene is a single copy
gene in various species including human and
rodents (ZIVIN et al., 1984; SEIDMAN et al.,
1985; LEWICKI et al., 1986; TAKEI et al.,
1997). Chemiluminescence applied to
Southern blotting has been referred to as a
very sensitive technique for DNA analysis
(SHEFFIELD et al., 1992). In the present
study, the Southern blot analysis of cat and
human digested genomic DNA revealed a
similar pattern of restriction enzymes
digestion. This was anticipated based on the
fact that ANP has highly conserved nucleotide
sequence among species (BIONDO et al.,
2002). If the feline ANP gene had more than
one copy, digestion with restriction enzyme
BamHI would result in either multiple bands or
different intensity/size when compared with
human ANP gene. Hence, the presence of
single bands with similar intensities for both
the cat and human ANP genes with digestion
by three separate restriction enzymes
suggests that the ANP gene exists as a single
copy in the feline genome as in human beings.
It should also be noted that the cDNA probe
used in these experiments for Southern
blotting, was effectively used with both feline
and human DNA, supporting the notion that
the nucleotide sequence of ANP among
species is highly conserved.
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